These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 11152850)
1. Effectiveness of high doses of simvastatin as monotherapy in mixed hyperlipidemia. Miller M; Dolinar C; Cromwell W; Otvos JD Am J Cardiol; 2001 Jan; 87(2):232-4, A9. PubMed ID: 11152850 [TBL] [Abstract][Full Text] [Related]
2. Atheroprotective lipoprotein effects of a niacin-simvastatin combination compared to low- and high-dose simvastatin monotherapy. Airan-Javia SL; Wolf RL; Wolfe ML; Tadesse M; Mohler E; Reilly MP Am Heart J; 2009 Apr; 157(4):687.e1-8. PubMed ID: 19332196 [TBL] [Abstract][Full Text] [Related]
3. Effectiveness and safety of alternate-day simvastatin and fenofibrate on mixed hyperlipidemia. Kayikçioğlu M; Ozerkan F; Soydan I Am J Cardiol; 1999 Apr; 83(7):1135-7, A9. PubMed ID: 10190536 [TBL] [Abstract][Full Text] [Related]
4. Effects of simvastatin (40 and 80 mg/day) in patients with mixed hyperlipidemia. Stein E; Plotkin D; Bays H; Davidson M; Dujovne C; Korenman S; Stepanavage M; Mercuri M Am J Cardiol; 2000 Aug; 86(4):406-11. PubMed ID: 10946033 [TBL] [Abstract][Full Text] [Related]
5. Changes in lipid metabolism and effect of simvastatin in renal transplant recipients induced by cyclosporine or tacrolimus. Ichimaru N; Takahara S; Kokado Y; Wang JD; Hatori M; Kameoka H; Inoue T; Okuyama A Atherosclerosis; 2001 Oct; 158(2):417-23. PubMed ID: 11583721 [TBL] [Abstract][Full Text] [Related]
6. [Controlled administration of simvastatin and common therapy of hyperlipidemia in patients with ischemic heart disease in outpatient conditions: comparative investigation of two strategies (SIGNAL-CONTROL)]. Ageev FT; Nuraliev EIu; Chernina GV; Vitsenia MV; Orlova IaA; Iarovaia EB; Kukharchuk VV Kardiologiia; 2006; 46(6):10-5. PubMed ID: 16883217 [No Abstract] [Full Text] [Related]
7. Fenofibrate plus simvastatin (fixed-dose combination) for the treatment of dyslipidaemia. Filippatos TD; Elisaf MS Expert Opin Pharmacother; 2011 Aug; 12(12):1945-58. PubMed ID: 21736529 [TBL] [Abstract][Full Text] [Related]
8. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial. de Lemos JA; Blazing MA; Wiviott SD; Lewis EF; Fox KA; White HD; Rouleau JL; Pedersen TR; Gardner LH; Mukherjee R; Ramsey KE; Palmisano J; Bilheimer DW; Pfeffer MA; Califf RM; Braunwald E; JAMA; 2004 Sep; 292(11):1307-16. PubMed ID: 15337732 [TBL] [Abstract][Full Text] [Related]
9. Comparative efficacy of ezetimibe/simvastatin, rosuvastatin, and atorvastatin in uncontrolled hyperlipidemia patients. Furman A; Meier JL; Malmstrom RA; Lopez JR; Schaefer S Am J Manag Care; 2011; 17(8):538-44. PubMed ID: 21851141 [TBL] [Abstract][Full Text] [Related]
10. [Efficacy and tolerability of statins in patients with primary hyperlipidemias]. Rozhkova TA; Susekov AV; Solov'eva EIu; Titov VN; Kukharchuk VV Kardiologiia; 2005; 45(9):32-4. PubMed ID: 16234790 [No Abstract] [Full Text] [Related]
11. Association of simvastatin and hyperlipidemia with periodontal status and bone metabolism markers. Magán-Fernández A; Papay-Ramírez L; Tomás J; Marfil-Álvarez R; Rizzo M; Bravo M; Mesa F J Periodontol; 2014 Oct; 85(10):1408-15. PubMed ID: 24555750 [TBL] [Abstract][Full Text] [Related]
12. Effect of Taizhi'an capsule combined with Simvastatin on hyperlipidemia in diabetic patients. Gao F; Hu XF Chin J Integr Med; 2006 Mar; 12(1):24-8. PubMed ID: 16571279 [TBL] [Abstract][Full Text] [Related]
13. Comparison of combined statin-fibrate treatment to monotherapy in patients with mixed hyperlipidemia. Kłosiewicz-Latoszek L; Szostak WB; Grzybowska B; Białobrzeska-Paluszkiewicz J; Wiśniewska B; Stolarska I Kardiol Pol; 2004 Jun; 60(6):567-77. PubMed ID: 15334157 [TBL] [Abstract][Full Text] [Related]
14. Current and future treatment of hyperlipidemia: the role of statins. Farnier M; Davignon J Am J Cardiol; 1998 Aug; 82(4B):3J-10J. PubMed ID: 9737640 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of fenofibric acid co-administered with low- or moderate-dose statin in patients with mixed dyslipidemia and type 2 diabetes mellitus: results of a pooled subgroup analysis from three randomized, controlled, double-blind trials. Jones PH; Cusi K; Davidson MH; Kelly MT; Setze CM; Thakker K; Sleep DJ; Stolzenbach JC Am J Cardiovasc Drugs; 2010; 10(2):73-84. PubMed ID: 20136164 [TBL] [Abstract][Full Text] [Related]
16. [Variability of the hypolipidemic action of simvastatin and fluvastatin in patients with primary hyperlipoproteinemia]. Tvorogova MG; Susekov AV; Semenova OA; Kukharchuk VV; Titov VN Ter Arkh; 1998; 70(12):8-13. PubMed ID: 10067240 [TBL] [Abstract][Full Text] [Related]
17. [Efficacy and safety of simvastatin in the treatment of hyperlipidemia in uremic patients undergoing hemodialysis treatment]. Fiorini F; Patrone E; Ardu F; Castelluccio A Minerva Urol Nefrol; 1992; 44(2):165-8. PubMed ID: 1411867 [TBL] [Abstract][Full Text] [Related]
18. Effects of simvastatin and pravastatin on hyperlipidemia and cyclosporin blood levels in renal transplant recipients. Capone D; Stanziale P; Gentile A; Imperatore P; Pellegrino T; Basile V Am J Nephrol; 1999; 19(3):411-5. PubMed ID: 10393380 [TBL] [Abstract][Full Text] [Related]
19. Efficacy, safety and effect on biomarkers related to cholesterol and lipoprotein metabolism of rosuvastatin 10 or 20 mg plus ezetimibe 10 mg vs. simvastatin 40 or 80 mg plus ezetimibe 10 mg in high-risk patients: Results of the GRAVITY randomized study. Ballantyne CM; Hoogeveen RC; Raya JL; Cain VA; Palmer MK; Karlson BW; Atherosclerosis; 2014 Jan; 232(1):86-93. PubMed ID: 24401221 [TBL] [Abstract][Full Text] [Related]
20. Statin therapy correlated CYP2D6 gene polymorphism and hyperlipidemia. Li J; Wang X; Zhang Z; Zou J; Chen Y; Wang X; Wu J Curr Med Res Opin; 2014 Feb; 30(2):223-8. PubMed ID: 24156754 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]